These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

883 related items for PubMed ID: 33137407

  • 1. EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulation.
    Alsahafi EN, Thavaraj S, Sarvestani N, Novoplansky O, Elkabets M, Ayaz B, Tavassoli M, Legends MF.
    Cancer Lett; 2021 Feb 01; 498():80-97. PubMed ID: 33137407
    [Abstract] [Full Text] [Related]

  • 2. Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapy.
    Pogorzelski M, Ting S, Gauler TC, Breitenbuecher F, Vossebein I, Hoffarth S, Markowetz J, Lang S, Bergmann C, Brandau S, Jawad JA, Schmid KW, Schuler M, Kasper S.
    Cell Death Dis; 2014 Feb 27; 5(2):e1091. PubMed ID: 24577089
    [Abstract] [Full Text] [Related]

  • 3. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
    Nantajit D, Presta L, Sauter T, Tavassoli M.
    Cell Death Dis; 2022 Nov 04; 13(11):921. PubMed ID: 36333293
    [Abstract] [Full Text] [Related]

  • 4. Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.
    Frederick BA, Gupta R, Atilano-Roque A, Su TT, Raben D.
    Radiat Res; 2020 Nov 10; 194(5):519-531. PubMed ID: 32936912
    [Abstract] [Full Text] [Related]

  • 5. 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
    Shi E, Wu Z, Karaoglan BS, Schwenk-Zieger S, Kranz G, Abdul Razak N, Reichel CA, Canis M, Baumeister P, Zeidler R, Gires O.
    J Biomed Sci; 2023 Aug 24; 30(1):72. PubMed ID: 37620936
    [Abstract] [Full Text] [Related]

  • 6. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
    Rampias T, Pectasides E, Prasad M, Sasaki C, Gouveris P, Dimou A, Kountourakis P, Perisanidis C, Burtness B, Zaramboukas T, Rimm D, Fountzilas G, Psyrri A.
    Ann Oncol; 2013 Aug 24; 24(8):2124-31. PubMed ID: 23406730
    [Abstract] [Full Text] [Related]

  • 7. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients.
    Brand TM, Hartmann S, Bhola NE, Peyser ND, Li H, Zeng Y, Isaacson Wechsler E, Ranall MV, Bandyopadhyay S, Duvvuri U, LaVallee TM, Jordan RCK, Johnson DE, Grandis JR.
    Clin Cancer Res; 2017 Jun 15; 23(12):3072-3083. PubMed ID: 27986750
    [Abstract] [Full Text] [Related]

  • 8. The radiobiology of HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Zhou C, Parsons JL.
    Expert Rev Mol Med; 2020 Jul 02; 22():e3. PubMed ID: 32611474
    [Abstract] [Full Text] [Related]

  • 9. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L, Kumar B, Shen C, Zhao S, Blakaj D, Li T, Romito M, Teknos TN, Williams TM.
    Mol Cancer Ther; 2019 Jun 02; 18(6):1025-1035. PubMed ID: 31015310
    [Abstract] [Full Text] [Related]

  • 10. 4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
    Shishodia G, Toledo RRG, Rong X, Zimmerman E, Xiao AY, Harrison L, Nathan CO.
    Oral Oncol; 2021 Nov 02; 122():105578. PubMed ID: 34695758
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Dok R, Bamps M, Glorieux M, Zhao P, Sablina A, Nuyts S.
    Int J Cancer; 2020 Feb 15; 146(4):1075-1085. PubMed ID: 31283004
    [Abstract] [Full Text] [Related]

  • 12. Effect of ATR Inhibition in RT Response of HPV-Negative and HPV-Positive Head and Neck Cancers.
    Dok R, Glorieux M, Bamps M, Nuyts S.
    Int J Mol Sci; 2021 Feb 03; 22(4):. PubMed ID: 33546122
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
    Ramesh PS, Bovilla VR, Swamy VH, Manoli NN, Dasegowda KB, Siddegowda SM, Chandrashekarappa S, Somasundara VM, Kabekkodu SP, Rajesh R, Devegowda D, Thimmulappa RK.
    Free Radic Biol Med; 2023 Aug 20; 205():234-243. PubMed ID: 37328018
    [Abstract] [Full Text] [Related]

  • 14. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y.
    Hum Pathol; 2016 Apr 20; 50():51-61. PubMed ID: 26997438
    [Abstract] [Full Text] [Related]

  • 15. BCCIPβ facilitates p53 ubiquitination via binding with E6 protein in high-risk HPV positive head and neck squamous cell carcinoma.
    Wang F, Wang J, Wang J, Zhang L, Fu H, Li J, Tian T, Zuo J, Lv W, Ma X.
    Biochem Biophys Res Commun; 2020 Aug 27; 529(3):685-691. PubMed ID: 32736693
    [Abstract] [Full Text] [Related]

  • 16. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J, Tang LL, Ma J.
    BMC Cancer; 2022 Jun 29; 22(1):714. PubMed ID: 35768785
    [Abstract] [Full Text] [Related]

  • 17. Combining Chk1/2 Inhibition with Cetuximab and Radiation Enhances In Vitro and In Vivo Cytotoxicity in Head and Neck Squamous Cell Carcinoma.
    Zeng L, Beggs RR, Cooper TS, Weaver AN, Yang ES.
    Mol Cancer Ther; 2017 Apr 29; 16(4):591-600. PubMed ID: 28138028
    [Abstract] [Full Text] [Related]

  • 18. Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status.
    Baysal H, De Pauw I, Zaryouh H, De Waele J, Peeters M, Pauwels P, Vermorken JB, Smits E, Lardon F, Jacobs J, Wouters A.
    Br J Cancer; 2020 Sep 29; 123(5):752-761. PubMed ID: 32541873
    [Abstract] [Full Text] [Related]

  • 19. Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest.
    Li C, Johnson DE.
    Cell Cycle; 2013 Mar 15; 12(6):923-34. PubMed ID: 23421999
    [Abstract] [Full Text] [Related]

  • 20. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
    Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, Heron DE, Grandis JR, Argiris A.
    Cancer; 2018 Oct 01; 124(19):3881-3889. PubMed ID: 30291796
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.